Abstract
Purpose
Mutations in RMRP primarily give rise to Cartilage Hair Hypoplasia (CHH), a highly diverse skeletal disorder which can be associated with severe immunodeficiency. Increased availability of RMRP mutation screening has uncovered a number of infants with significant immunodeficiency but only mild or absent skeletal features. We surveyed the clinical and immunological phenotype of children who have undergone allogeneic haematopoietic stem cell transplantation for this condition in the UK.
Methods
Thirteen patients with confirmed RMRP mutations underwent allogeneic stem cell transplantation (SCT) at two nationally commissioned centres using a variety of donors and conditioning regimens. Records were retrospectively reviewed.
Results
Median time from clinical presentation to diagnosis was 12 months (range 1 to 276 months), with three infants diagnosed with severe combined immunodeficiency (SCID) without radiographical manifestations of CHH. A total of 17 allogeneic procedures were performed on 13 patients including two stem-cell top-ups. The median age at transplant was 32.4 months (range 1.5 to 125 months). Of the eleven surviving patients, median follow-up was 50 months (range 21.6 to 168 months).
Conclusions
RMRP mutations can cause short stature and significant immunodeficiency which can be corrected by allogeneic SCT and the diagnosis should be considered even in the absence of skeletal manifestations.
Similar content being viewed by others
Abbreviations
- CHH:
-
Cartilage hair hypoplasia
- RMRP:
-
Ribonuclease mitochondrial RNA processing
- SCT:
-
Stem cell transplantation
- SCID:
-
Severe combined immunodeficiency
References
McKusick VA, Eldridge R, Hostetler JA, Ruangwit U, Egeland JA. Dwarfism in the Amish. Ii. Cartilage-Hair Hypoplasia. Bull Johns Hopkins Hosp. 1965;116:285–326.
Hermanns P, Bertuch AA, Bertin TK, Dawson B, Schmitt ME, Shaw C, et al. Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet. 2005;14(23):3723–40.
Ridanpaa M, Sistonen P, Rockas S, Rimoin DL, Makitie O, Kaitila I. Worldwide mutation spectrum in cartilage-hair hypoplasia: ancient founder origin of the major70A–>G mutation of the untranslated RMRP. Eur J Hum Genet : EJHG. 2002;10(7):439–47.
Nakashima E, Mabuchi A, Kashimada K, Onishi T, Zhang J, Ohashi H, et al. RMRP mutations in Japanese patients with cartilage-hair hypoplasia. Am J Med Genet A. 2003;123A(3):253–6.
Hermanns P, Tran A, Munivez E, Carter S, Zabel B, Lee B, et al. RMRP mutations in cartilage-hair hypoplasia. Am J Med Genet A. 2006;140(19):2121–30.
Makitie O, Marttinen E, Kaitila I. Skeletal growth in cartilage-hair hypoplasia. A radiological study of 82 patients. Pediatr Radiol. 1992;22(6):434–9.
Glass RB, Tifft CJ. Radiologic changes in infancy in McKusick cartilage hair hypoplasia. Am J Med Genet. 1999;86(4):312–5.
Kwan A, Manning MA, Zollars LK, Hoyme HE. Marked variability in the radiographic features of cartilage-hair hypoplasia: case report and review of the literature. Am J Med Genet A. 2012;158A(11):2911–6.
Makitie O, Kaitila I. Cartilage-hair hypoplasia–clinical manifestations in 108 Finnish patients. Eur J Pediatr. 1993;152(3):211–7.
Makitie O, Sulisalo T, de la Chapelle A, Kaitila I. Cartilage-hair hypoplasia. J Med Genet. 1995;32(1):39–43.
Moshous D, Meyts I, Fraitag S, Janssen CE, Debre M, Suarez F, et al. Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-alpha mAbs. J Allergy Clin Immunol. 2011;128(4):847–53.
McCann LJ, McPartland J, Barge D, Strain L, Bourn D, Calonje E, et al. Phenotypic variations of cartilage hair hypoplasia: granulomatous skin inflammation and severe T cell immunodeficiency as initial clinical presentation in otherwise well child with short stature. J Clin Immunol. 2014;34(1):42–8.
Ridanpaa M, van Eenennaam H, Pelin K, Chadwick R, Johnson C, Yuan B, et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell. 2001;104(2):195–203.
Clayton DA. A big development for a small RNA. Nature. 2001;410(6824):29. 31.
Thiel CT, Rauch A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. Best Pract Res Clin Endocrinol Metab. 2011;25(1):131–42.
Kavadas FD, Giliani S, Gu Y, Mazzolari E, Bates A, Pegoiani E, et al. Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations. J Allergy Clin Immunol. 2008;122(6):1178–84.
Roifman CM, Gu Y, Cohen A. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. J Allergy Clin Immunol. 2006;117(4):897–903.
Bordon V, Gennery AR, Slatter MA, Vandecruys E, Laureys G, Veys P, et al. Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation. Blood. 2010;116(1):27–35.
Gaspar HB, Cooray S, Gilmour KC, Parsley KL, Zhang F, Adams S, et al. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med. 2011;3(97):97ra80.
Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet. 2004;364(9452):2181–7.
Gerstel-Thompson JL, Wilkey JF, Baptiste JC, Navas JS, Pai SY, Pass KA, et al. High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening. Clin Chem. 2010;56(9):1466–74.
Bonafe L, Dermitzakis ET, Unger S, Greenberg CR, Campos-Xavier BA, Zankl A, et al. Evolutionary comparison provides evidence for pathogenicity of RMRP mutations. PLoS Genet. 2005;1(4):e47.
Rider NL, Morton DH, Puffenberger E, Hendrickson CL, Robinson DL, Strauss KA. Immunologic and clinical features of 25 Amish patients with RMRP 70 A–>G cartilage hair hypoplasia. Clin Immunol. 2009;131(1):119–28.
Notarangelo LD, Roifman CM, Giliani S. Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol. 2008;8(6):534–9.
Le Merrer M, Maroteaux P. Cartilage hair hypoplasia in infancy: a misleading chondrodysplasia. Eur J Pediatr. 1991;150(12):847–51.
Kuijpers TW, Ridanpaa M, Peters M, de Boer I, Vossen JM, Pals ST, et al. Short-limbed dwarfism with bowing, combined immune deficiency, and late onset aplastic anaemia caused by novel mutations in the RMPR gene. J Med Genet. 2003;40(10):761–6.
Bonafe L, Schmitt K, Eich G, Giedion A, Superti-Furga A. RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphisms. Clin Genet. 2002;61(2):146–51.
Makitie O, Kaitila I, Savilahti E. Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr. 1998;157(10):816–20.
Kwan A, Church JA, Cowan MJ, Agarwal R, Kapoor N, Kohn DB, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol. 2013;132(1):140–50.
Thiel CT, Mortier G, Kaitila I, Reis A, Rauch A. Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum. Am J Hum Genet. 2007;81(3):519–29.
Taskinen M, Ranki A, Pukkala E, Jeskanen L, Kaitila I, Makitie O. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am J Med Genet A. 2008;146A(18):2370–5.
Makitie O, Pukkala E, Teppo L, Kaitila I. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr. 1999;134(3):315–8.
de Latour RP, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122(26):4279–86.
Brown J, Morfopoulou S, Hubb J, Emmett W, Ip W, Shah D, et al. Astrovirus VA1/HMO-C: an increasingly recognised neurotropic pathogen in immunocompromised patients. Clin Infect Dis 2014
Acknowledgments
The authors would like to thank Kerra Pearce and Mike Hubank (UCL Genomics) for their assistance with microarrays and NGS work.
Funding Source
This work was undertaken at GOSH/UCL Institute of Child Health which received funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme and GOSH charity special trustees. The UK service for primary immunodeficiency received support from the Department of Health via the national commissioning group (NCG).
Financial Disclosure
Winnie Ip has no financial relationships relevant to this article. All the other authors also have no financial disclosures relevant to this article.
Conflict of Interest
Winnie Ip has no conflict of interest to disclose. All the other authors also have no conflicts of interest relevant to this article to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ip, W., Gaspar, H.B., Kleta, R. et al. Variable Phenotype of Severe Immunodeficiencies Associated with RMRP Gene Mutations. J Clin Immunol 35, 147–157 (2015). https://doi.org/10.1007/s10875-015-0135-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-015-0135-7